VERFUEGBARKEITSPRUEFUNG IN VITRO-ERFORDERNIS, MOEGLICHKEITEN, GRENZEN = RECHERCHE DE LA BIODISPONIBILITE IN VITRO. EXIGENCES, POSSIBILITES, LIMITESDIBBERN HW.1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 2; PP. 76-78; ABS. ANGL.; BIBL. 50 REF.Serial Issue

BIOPHARMACEUTICAL FACTORS INFLUENCING LD₅₀. II. PARTICLE SIZE = FACTEURS BIOPHARMACEUTIQUES INFLUANT SUR LA DL50. II. DIMENSION DES PARTICULESRITSCHEL WA; RING PE; SIEGEL EG et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 6; PP. 853-856; ABS. ALLEM.; BIBL. 12REF.Article

PHARMACOCINETIQUE ET SECURITE EN MATIERE DE MEDICAMENTDEVISSAGUET JP.1973; IN: JOURN. PHARM. INT. PARIS, SECUR. MATIERE MED.; PARIS; 1972; PARIS; SOC. ED. PHARM. SCI.; DA. 1973; PP. 75-86; BIBL. 17REF.Conference Paper

BEEINFLUSSUNG DER ARZNEIMITTELWIRKUNG DURCH DIE ARZNEIFORM = INFLUENCE DE LA FORME PHARMACEUTIQUE SUR L'ACTIVITE DU MEDICAMENTZATHURECKY L.1972; PHARMAZIE; DTSCH.; DA. 1972; VOL. 27; NO 11; PP. 686-693; BIBL. 25REF.Serial Issue

LES POMMADES. IV.LA LIBERATION ET L'ABSORPTION DES SUBSTANCES MEDICAMENTEUSES A PARTIR DES EXCIPIENTS POUR POMMADES ET LES FACTEURS QUI INFLUENT SUR L'EFFICACITE THERAPEUTIQUE DES POMMADESPERTSEV YI M; BASHURA GS; SALO DP et al.1972; FARM. ZH., U.R.S.R.; S.S.S.R.; DA. 1972; VOL. 27; NO 6; PP. 15-22; BIBL. 1P.1/2Serial Issue

AKTUAL'NYE PROBLEMY BIOFARMATSII: SBORNIK NAUCHNYKH TRUDOV = PROBLEMES ACTUELS DE LA BIOPHARMACIETENTSOVAYA AI.1978; ; SUN; MOSKVA: 1 M.M.I. IM. I.M. SECHENOVA; DA. 1978; 120 P.: ILL.; 20 CM; BIBL. DISSEM.Book

PREDICTION OF SYSTEMIC AVAILABILITY FROM PLASMA-LEVEL DATA AFTER ORAL DRUG ADMINISTRATION = LA PREDICTION DE LA DISPONIBILITE GENERALE D'APRES LES DONNEES DU TAUX PLASMATIQUE APRES L'ADMINISTRATION PER OS DES MEDICAMENTSPERRIER D; GIBALDI M; BOYES RN et al.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 3; PP. 256-257; BIBL. 7 REF.Serial Issue

BIOPHARMAZIE DER INJEKTABILIA. I. INJECTABILIA MIT SOFORTWIRKUNG = BIOPHARMACIE DES PRODUITS INJECTABLES. I. PRODUITS INJECTABLES AVEC UNE ACTION IMMEDIATE1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 5; PP. 273-285; ABS. ANGL.; BIBL. 119REF.Serial Issue

SALICYLATE RELEASE CHARACTERISTICS OF SELECTED POLYETHYLENE GLYCOL SUPPOSITORIES = CARACTERISTIQUES DE LA LIBERATION DE SALICYLATES A PARTIR DE SUPPOSITOIRES EN POLYETHYLENE GLYCOLS SELECTIONNESPUFFER HW; CROWELL WJ.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 2; PP. 242-245; BIBL. 16 REF.Serial Issue

PHARMACOKINETICS AND BIOPHARMACEUTICS OF SOME ADRENERGIC BETA RECEPTOR ANTAGONISTS WITH SPECIAL EMPHASIS ON ALPRENOLOL AND METOPROLOLREGARDH CG.1975; ACTA PHARMACOL. TOXICOL., SUPPL.; DANEM.; DA. 1975; VOL. 37; NO 1; PP. 1-39; BIBL. 4P.Article

SOME BIOPHARMACEUTICAL STUDIES OF EMULSIONS OF THE O/W TYPE. I. COMMUNICATION = QUELQUES ETUDES BIOPHARMACEUTIQUES DES EMULSIONS DU TYPE HUILE/EAU. IERE COMMUNICATIONMINKOV E; OVCHAROV R; MIHAILOVA D et al.1974; PHARM. INDUSTR.; DTSCH.; DA. 1974; VOL. 36; NO 6; PP. 446-449; ABS. ANGL.; BIBL. 7REF.Article

ROLE OF DRUG METABOLISM IN DRUG RESEARCH AND DEVELOPMENT: PHARMACEUTICAL CHEMISTRY ASPECTSHEIMLICH KR.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1686-1689; BIBL. 8REF.Serial Issue

VARIATIONS IN THEOPHYLLINE, EPHEDRINE HYDROCHLORIDE AND PHENOBARBITAL TABLETS MANUFACTURED BY THIRTEEN FIRMSLACH JL; TING FONG CHIN; PARROTT EL et al.1972; AMER. J. HOSP. PHARM.; U.S.A.; DA. 1972; VOL. 29; NO 12; PP. 1043-1047; BIBL. 9 REF.Serial Issue

ROCEEDINGS OF THE CONFERENCE ON BIOAVAILABILITY OF DRUGS AT THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, WASHINGTON, D.C., NOVEMBER 22-23, 1971 = COMPTE RENDUS DE LA CONFERENCE SUR LA BIODISPONIBILITE DES MEDICAMENTS A L'ACADEMIE NATIONALE DES SCIENCES DES ETATS-UNIS, WASHINGTON, D.C., 22-23 NOVEMBRE 19711972; PHARMACOLOGY; SWITZ.; DA. 1972; VOL. 8; NO 1-3; PP. 3-215; BIBL. DISSEM.Serial Issue

GENERIC EQUIVALENCE: A LOOK AT THE LITERATUREFLORENCE AT.1972; INDIAN J. PHARM.; INDIA; DA. 1972; VOL. 34; NO 6; PP. 129-146; BIBL. 2 P.Serial Issue

THE ABSORPTION AND METABOLISM IN MAN OF 4-ACETAMIDOPHENYL-2-ACETOXYBENZOATE (BENORYLATE)ROBERTSON A; GLYNN JP; WATSON AK et al.1972; XENOBIOTICA; G.B.; DA. 1972; VOL. 2; NO 4; PP. 339-347; BIBL. 16 REF.Serial Issue

IN VITRO-VERSUCHE ZUM PROBLEM GALENISCHE ZUBEREITUNGEN ODER REINSUBSTANZ = ESSAIS IN VITRO CONCERNANT: LES PREPARATIONS GALENIQUES OU LES SUBSTANCES PURESCSUPOR L.1972; PLANTA MED.; ALLEM.; DA. 1972; VOL. 22; NO 4; PP. 365-377; ABS. ANGL.; BIBL. 1P.Serial Issue

ASPECTS BIOPHARMACEUTIQUES DES PREPARATIONS MEDICAMENTEUSE PAR VOIE RECTALENEUWALD F.1972; PHARMA INTERNATION.; ALLEM.; DA. 1972; NO 2; PP. 5-11 (6P.); BIBL. 11REF.Serial Issue

Dutch Society of Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 918-931, issn 0306-5251, 14 p.Conference Paper

Commercialization of biopharmaceutical and bioindustrial proteins from plants : Genetic and metabolic engineering for value-added traitsHOWARD, John A.Crop science. 2005, Vol 45, Num 2, pp 468-472, issn 0011-183X, 5 p.Article

Polymeric delivery systems for biopharmaceuticalsDINARVAND, Rassoul; DORKOOSH, Farid; HAMIDI, Mehrdad et al.Biotechnology & genetic engineering reviews. 2004, Vol 21, pp 147-181, issn 0264-8725, 35 p.Article

Biopharmaceutics classification by high throughput solubility assay and PAMPAOBATA, Kouki; SUGANO, Kiyohiko; MACHIDA, Minoru et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 181-185, issn 0363-9045, 5 p.Article

THE KINETIC BEHAVIOUR OF PHENYLBUTAZONE IN FOUR SOLVENT SYSTEMS = CINETIQUE DE LA PHENYLBUTAZONE DANS QUATRE SYSTEMES DE SOLVANTSSLINGSBY J; ZUCK DA.1972; CANAD. J. PHARM. SCI.; CANADA; DA. 1972; VOL. 7; NO 4; PP. 115-116; ABS. FR.; BIBL. 4REF.Serial Issue

VERGLEICHENDE UNTERSUCHUNGEN DER ENZYMAKTIVITAET EINIGER PANKREATINPRAEPARATE = ETUDES COMPARATIVES SUR L'ACTIVITE ENZYMATIQUE DE QUELQUES PREPARATIONS DE PANCREATINE1972; DTSCHE APOTHEKER-ZTG; DTSCH.; DA. 1972; VOL. 112; NO 50; PP. 2005-2009; BIBL. 20 REF.Serial Issue

Comment sécuriser les traitements par les biomédicaments ? = How to optimize biopharmaceutical treatment safety ?PRUGNAUD, Jean-Louis.Bulletin de l'Académie nationale de médecine. 2011, Vol 195, Num 3, pp 679-695, issn 0001-4079, 17 p.Article